Causes of death with and without LONIPCs
. | Non-LONIPCs . | . | LONIPCs . | . | ||
|---|---|---|---|---|---|---|
| Causes of death . | Patients, N = 58 . | % . | Patients, N = 18 . | % . | ||
| Relapse | 12 | 66.7 | 1 | 12.5 | ||
| GVHD | 3 | 16.7 | 0 | 0 | ||
| TMA | 1 | 5.6 | 0 | 0 | ||
| Infection | 1 | 5.6 | 1 | 12.5 | ||
| Second malignancy | 1 | 5.6 | 1 | 12.5 | ||
| Respiratory failure due to LONIPCs | 0 | 0 | 5 | 62.5 | ||
. | Non-LONIPCs . | . | LONIPCs . | . | ||
|---|---|---|---|---|---|---|
| Causes of death . | Patients, N = 58 . | % . | Patients, N = 18 . | % . | ||
| Relapse | 12 | 66.7 | 1 | 12.5 | ||
| GVHD | 3 | 16.7 | 0 | 0 | ||
| TMA | 1 | 5.6 | 0 | 0 | ||
| Infection | 1 | 5.6 | 1 | 12.5 | ||
| Second malignancy | 1 | 5.6 | 1 | 12.5 | ||
| Respiratory failure due to LONIPCs | 0 | 0 | 5 | 62.5 | ||
TMA indicates thrombotic microangiopathy.